AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 145 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.31 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $528,041 | +43.7% | 21,335 | +64.4% | 0.00% | +100.0% |
Q2 2023 | $367,537 | +190.3% | 12,978 | +135.5% | 0.00% | – |
Q1 2023 | $126,588 | +48.4% | 5,511 | +81.5% | 0.00% | – |
Q4 2022 | $85,279 | +60.9% | 3,037 | +60.8% | 0.00% | – |
Q3 2022 | $53,000 | -94.0% | 1,889 | -95.3% | 0.00% | -100.0% |
Q2 2022 | $885,000 | -58.1% | 39,920 | -45.0% | 0.00% | -50.0% |
Q1 2022 | $2,112,000 | +830.4% | 72,546 | +1376.3% | 0.00% | – |
Q3 2021 | $227,000 | -50.9% | 4,914 | -53.9% | 0.00% | -100.0% |
Q4 2020 | $462,000 | +402.2% | 10,661 | +305.8% | 0.00% | – |
Q3 2020 | $92,000 | -92.7% | 2,627 | -92.6% | 0.00% | -100.0% |
Q1 2020 | $1,266,000 | +569.8% | 35,677 | +512.2% | 0.01% | +400.0% |
Q3 2019 | $189,000 | +1790.0% | 5,828 | +2814.0% | 0.00% | – |
Q2 2019 | $10,000 | -87.3% | 200 | -82.8% | 0.00% | -100.0% |
Q1 2019 | $79,000 | -65.5% | 1,164 | -76.6% | 0.00% | -50.0% |
Q4 2018 | $229,000 | -5.0% | 4,976 | +68.6% | 0.00% | 0.0% |
Q1 2018 | $241,000 | -85.1% | 2,951 | -89.5% | 0.00% | -81.8% |
Q4 2017 | $1,613,000 | +4.8% | 28,222 | +22.4% | 0.01% | -21.4% |
Q3 2017 | $1,539,000 | +36.7% | 23,055 | +5.3% | 0.01% | +16.7% |
Q2 2017 | $1,126,000 | +63.2% | 21,887 | +85.4% | 0.01% | +50.0% |
Q1 2017 | $690,000 | -23.0% | 11,808 | -45.0% | 0.01% | -11.1% |
Q4 2016 | $896,000 | +64.4% | 21,462 | +108.2% | 0.01% | +50.0% |
Q3 2016 | $545,000 | -4.4% | 10,310 | -24.2% | 0.01% | -14.3% |
Q2 2016 | $570,000 | +9.4% | 13,607 | +6.1% | 0.01% | 0.0% |
Q1 2016 | $521,000 | +196.0% | 12,825 | +372.0% | 0.01% | +250.0% |
Q4 2015 | $176,000 | +450.0% | 2,717 | +495.8% | 0.00% | – |
Q3 2015 | $32,000 | -87.4% | 456 | -83.1% | 0.00% | -100.0% |
Q1 2015 | $254,000 | -11.2% | 2,695 | +5.6% | 0.00% | 0.0% |
Q4 2014 | $286,000 | – | 2,552 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BB BIOTECH AG | 2,719,998 | $155,502,000 | 4.38% |
Casdin Capital, LLC | 295,000 | $16,865,000 | 4.11% |
Opaleye Management Inc. | 130,000 | $7,432,000 | 2.38% |
Opus Point Partners Management, LLC | 28,704 | $1,641,000 | 1.42% |
Fernwood Investment Management, LLC | 27,550 | $1,575,000 | 0.84% |
Rhenman & Partners Asset Management AB | 100,000 | $5,717,000 | 0.77% |
COLUMBIA WANGER ASSET MANAGEMENT LLC | 760,116 | $43,456,000 | 0.65% |
Eventide Asset Management | 214,000 | $12,234,000 | 0.64% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 262,984 | $15,035,000 | 0.59% |
CAPITAL GUARDIAN TRUST CO | 663,089 | $37,909,000 | 0.54% |